Literature DB >> 9347822

Surreptitious superwarfarin poisoning with brodifacoum.

C Tecimer1, L T Yam.   

Abstract

Because of the emergence of warfarin resistance in rodents, second-generation anticoagulants named "superwarfarins" were developed and marketed in over-the-counter rodenticide products. The availability of these compounds has resulted in accidental or intentional human ingestions, which cause severe bleeding. The methods for diagnosis and treatment of patients using superwarfarins are different from those for patients taking the regular warfarins. We report a case of intentional superwarfarin ingestion that caused petechiae and hematuria. Although the patient denied taking anticoagulant, the persistence of vitamin K-dependent factor deficiency led us to investigate the serum for anticoagulant rodenticides. We found high levels of brodifacoum, a superwarfarin compound. This case emphasizes the need for suspicion of superwarfarin poisoning in patients who show unexplained bleeding due to deficiency of vitamin K-dependent factors and resistance to treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9347822     DOI: 10.1097/00007611-199710000-00018

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  An unexpected case of coumarin poisoning with coumatetralyl.

Authors:  Amin Kay; Leo Chiu; Christopher A K Y Chong
Journal:  BMJ Case Rep       Date:  2011-04-13

2.  Case of the month: "Oh! Drat!--A case of transcutaneous superwarfarin poisoning and its recurrent presentation".

Authors:  Simon Binks; Phil Davies
Journal:  Emerg Med J       Date:  2007-04       Impact factor: 2.740

3.  Severe Vitamin K-dependent Coagulopathy from Rodenticide-contaminated Synthetic Cannabinoids: Emergency Department Presentations.

Authors:  Erik Wright; John W Hafner; Gregory Podolej; Douglas L Feinstein; Richard van Breemen; Israel Rubinstein; Steven Aks; Michael Wahl
Journal:  West J Emerg Med       Date:  2021-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.